Although most Klebsiella pneumoniae liver abscesses have been reported to be monomicrobial, clinical outcomes have not been compared between antimicrobial therapy with and without anti-anaerobic coverage. A propensity score–matched cohort study was conducted using the 731 cases of K. pneumoniae liver abscess. Clinical outcomes were compared between a group discontinuing anti-anaerobic agents after K. pneumoniae identification and a group continuing. A total of 170 cases were matched at a 1:1 ratio using their propensity to discontinue antianaerobic agents. The McNemar's test showed no difference in mortality rates (1.8% for discontinuation versus 2.3% for continuation; P =1.00) or relapse (1.8% versus 2.9%; P= 0.73) between groups. Early discontinuation of anti-anaerobic agents had no association with treatment failure by means of the generalized estimating equation model (odds ratio 0.48; P=0.14) and the Kaplan–Meier method (P=0.85) in matched groups. Early discontinuation of anti-anaerobic agents does not affect the clinical outcomes of patients with K. pneumoniae liver abscess.
Hyun Ah Kim et al. (2015). Anti-anaerobic coverage is not necessary for Klebsiella pneumoniae liver abscess: a propensity score–matched cohort study. Diagnostic Microbiology and Infectious Disease, 81(1), 60–65. doi: 10.1016/j.diagmicrobio.2014.10.002